In contrast to the change of BTLA expression on circulating CD4+ T cells in HCC patients, we did not observe significant difference of HVEM expression on circulating CD4+ T cells in HCC patients as compared to that of HD (Figure 2(a)). The gene discussed is CD4; the disease is hepatocellular carcinoma.